Full text
PDFPage 309
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bost K. L., Blalock J. E. Molecular characterization of a corticotropin (ACTH) receptor. Mol Cell Endocrinol. 1986 Jan;44(1):1–9. doi: 10.1016/0303-7207(86)90099-7. [DOI] [PubMed] [Google Scholar]
- Bost K. L., Smith E. M., Blalock J. E. Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1372–1375. doi: 10.1073/pnas.82.5.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brentani R. R., Ribeiro S. F., Potocnjak P., Pasqualini R., Lopes J. D., Nakaie C. R. Characterization of the cellular receptor for fibronectin through a hydropathic complementarity approach. Proc Natl Acad Sci U S A. 1988 Jan;85(2):364–367. doi: 10.1073/pnas.85.2.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carr D. J., Bost K. L., Blalock J. E. An antibody to a peptide specified by an RNA that is complementary to gamma-endorphin mRNA recognizes an opiate receptor. J Neuroimmunol. 1986 Oct;12(4):329–337. doi: 10.1016/0165-5728(86)90039-1. [DOI] [PubMed] [Google Scholar]
- Carr D. J., DeCosta B., Jacobson A. E., Bost K. L., Rice K. C., Blalock J. E. Immunoaffinity-purified opiate receptor specifically binds the delta-class opiate receptor ligand, cis-(+)-3-methylfentanylisothiocyanate, SUPERFIT. FEBS Lett. 1987 Nov 30;224(2):272–276. doi: 10.1016/0014-5793(87)80468-4. [DOI] [PubMed] [Google Scholar]
- Elton T. S., Dion L. D., Bost K. L., Oparil S., Blalock J. E. Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2518–2522. doi: 10.1073/pnas.85.8.2518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Escher E., Mackiewicz Z., Lagacé G., Lehoux J. G., Gallo-Payet N., Bellabarba D., Bélisle S. Human placental LHRH receptor: agonist and antagonist labeling produces differences in the size of the non-denatured, solubilized receptor. J Recept Res. 1988;8(1-4):391–405. doi: 10.3109/10799898809049000. [DOI] [PubMed] [Google Scholar]
- Guillemette G., Balla T., Baukal A. J., Spät A., Catt K. J. Intracellular receptors for inositol 1,4,5-trisphosphate in angiotensin II target tissues. J Biol Chem. 1987 Jan 25;262(3):1010–1015. [PubMed] [Google Scholar]
- Guillemette G., Bernier M., Parent P., Leduc R., Escher E. Angiotensin II: dependence of hormone affinity on the electronegativity of a single side chain. J Med Chem. 1984 Mar;27(3):315–320. doi: 10.1021/jm00369a015. [DOI] [PubMed] [Google Scholar]
- Guillemette G., Escher E. Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method. Biochemistry. 1983 Nov 22;22(24):5591–5596. doi: 10.1021/bi00293a021. [DOI] [PubMed] [Google Scholar]
- Guillemette G., Guillon G., Marie J., Balestre M. N., Escher E., Jard S. High yield photoaffinity labeling of angiotensin II receptors. Mol Pharmacol. 1986 Dec;30(6):544–551. [PubMed] [Google Scholar]
- Görcs T. J., Gottschall P. E., Coy D. H., Arimura A. Possible recognition of the GnRH receptor by an antiserum against a peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide. Peptides. 1986 Nov-Dec;7(6):1137–1145. doi: 10.1016/0196-9781(86)90144-0. [DOI] [PubMed] [Google Scholar]
- Mulchahey J. J., Neill J. D., Dion L. D., Bost K. L., Blalock J. E. Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9714–9718. doi: 10.1073/pnas.83.24.9714. [DOI] [PMC free article] [PubMed] [Google Scholar]